Industry News
Merck named Best Bioprocessing Supplier in Asia
Science and technology company Merck was named the Best Bioprocessing Supplier at the Asia-Pacific Bioprocessing Excellence Awards 2018, held earlier this year. [ + ]
Clinical study commences for brain cancer drug
Kazia Therapeutics' small molecule inhibitor is being developed to treat glioblastoma multiforme — the most common and aggressive form of primary brain cancer. [ + ]
Face-matching technology helps diagnose intellectual disability
The Hunter Medical Research Institute has launched a web platform that will help unravel the mysteries behind undiagnosed intellectual disabilities in children. [ + ]
Phospholipid formulation found to relieve PMS
A clinical study has indicated the positive effects of Lipogen PMS, a natural phospholipid formulation, in treating and relieving premenstrual syndrome (PMS) symptoms. [ + ]
How much does cancer cost the Australian economy?
Experiencing cancer is tough for any patient, as well as their family and friends. But it seems that cancer is also not great for the Australian economy. [ + ]
Clinical trials centre adopts unified data management platform
The NHMRC Clinical Trial Centre will use technology company Medidata's unified platform and analytics for all major new studies starting in 2018. [ + ]
Chris Goodnow appointed as executive director of Garvan
The Garvan Institute of Medical Research has appointed Professor Chris Goodnow as its executive director. [ + ]
Optimum treatment for advanced melanoma patients revealed
Researchers now have greater clarity on the best course of treatment for patients with advanced melanoma which has spread to the brain. [ + ]
Artificial enzymes use light to kill bacteria
Made from tiny nanorods, the newly developed 'NanoZymes' use visible light to create highly reactive oxygen species that rapidly break down and kill bacteria. [ + ]
Want to help trial a vaccine for coeliac disease?
The University of the Sunshine Coast's Clinical Trials Centre has launched a clinical trial of a new vaccine that aims to switch off the immune response to gluten. [ + ]
Medical cannabis conference coming to Sydney
CannaTech AU will highlight industry thought leaders from Australia and around the world who are known for their contributions to the global medical cannabis market. [ + ]
New anticancer protein found to suppress liver tumours
A newly discovered anticancer protein has been found to prevent the uncontrolled proliferation of cancer cells in the liver. [ + ]
Why are rheumatoid arthritis patients at risk of heart disease?
Treating rheumatoid arthritis patients with a high-density lipoprotein (HDL) may limit their risk of developing heart disease, according to Melbourne researchers. [ + ]
The gene mutation that wards off malaria
Researchers have shed light on how humans who live in close quarters with malaria-carrying mosquitoes may evolve defences against the disease. [ + ]
Drug hoped to treat CFS causes impaired immune function — study
Reports that a drug used to treat autoimmune diseases and cancer could also treat CFS have been refuted by a new Griffith University study. [ + ]
